PMS69 Tumor Necrosis Factor Blocker Dose Escalation among Biologic Naïve Rheumatoid Arthritis (RA) Patients in Commercial Managed Care Plans in the Two Years Following Therapy Initiation

✍ Scribed by M. Bonafede; S.R. Gandra; K.M. Fox; K. Wilson

• Book ID: 119311200
• Publisher: John Wiley and Sons
• Year: 2012
• Tongue: English
• Weight: 59 KB
• Volume: 15
• Category: Article
• ISSN: 1098-3015
• DOI: 10.1016/j.jval.2012.03.258